Oncology

Upcoming FDA-AACR Workshop Will Discuss DPD Deficiency Testing

When the chemotherapy drug 5-fluorouracil (5-FU) was approved in 1962, there was limited understanding of how it is metabolized by the body. What was clear, however, was its efficacy against cancer. Today, 5-FU and a related drug called capecitabine are commonly used in cancer treatment, but we now know that rare genetic variants can increase […]

The post Upcoming FDA-AACR Workshop Will Discuss DPD Deficiency Testing appeared first on American Association for Cancer Research (AACR).

Source: Oncology